Skip to content

pharmaceuticals.co.nz

Drugs, medicines and medical news
Main navigation

Month: August 2021

Covid 19: Most patients in England received good or excellent care in hospital, finds analysis

Most patients admitted to hospitals in England with SARS-CoV-2 in 2020 received good care despite the challenges of […]

August 2, 2021 COVID-19

Takeda still on the hook for €398M tax linked to distant AbbVie-Shire breakup fee

Takeda still on the hook for €398M tax linked to distant AbbVie-Shire breakup fee fkansteiner Mon, 08/02/2021 – […]

August 2, 2021 Uncategorized

J&J notches a win in $50M talc lawsuit, but tens of thousands still pending

J&J notches a win in $50M talc lawsuit, but tens of thousands still pending bbulik Mon, 08/02/2021 – […]

August 2, 2021 Uncategorized

Pfizer, Moderna hike COVID-19 vaccine prices in new European supply deals: report

Pfizer, Moderna hike COVID-19 vaccine prices in new European supply deals: report fkansteiner Mon, 08/02/2021 – 09:34

August 2, 2021 Uncategorized

Purnell W Choppin: led the Howard Hughes Medical Institute from hope to prominence

bmj;374/aug02_1/n1887/FAF1faPhoto credit: Paul FettersHoward Hughes was one of the most flamboyant billionaires of the mid-20th century. Think Elon […]

August 2, 2021 Uncategorized

Sixty seconds on . . . cupping

Up for the cup?Some people are. The alternative therapy of cupping—thought to have originated in Middle Eastern and […]

August 2, 2021 Uncategorized

MHRA to shed a fifth of its workforce in post-Brexit cost cutting drive

The UK’s drug and medical devices regulator is to lose a substantial number of staff as part of […]

August 2, 2021 Uncategorized

AZ’s Saphnelo scores US approval for systemic lupus erythematosus

Saphnelo is the first type I interferon receptor agonist to receive regulatory approval

August 2, 2021 Uncategorized

EC approves BMS’ Opdivo as adjuvant treatment for oesophageal or GEJ cancer patients

The approval is based on Phase III results from the CheckMate-577 trial

August 2, 2021 Uncategorized

UCB’s bimekizumab issued NICE recommendation for severe plaque psoriasis

Bimekizumab is the first to follow NICE’s new expedited appraisal process

August 2, 2021 Uncategorized

Posts navigation

Posts pagination

« Previous 1 … 42 43 44 Next »
Proudly powered by WordPress | Theme: Hive Lite by Pixelgrade.
Footer navigation
  • Privacy Policy